J. B. Chemicals & Pharmaceuticals Limited held its 50th Annual General Meeting (AGM) on Wednesday, June 17, 2026 at 3:00 PM IST. The meeting was conducted through Video Conference (VC)/Other Audio Visual Means (OAVM) in compliance with the Companies Act, 2013, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and multiple circulars from the Ministry of Corporate Affairs and SEBI including General Circular No. 3/2025 dated September 22, 2025.
Attendance included 60 members present through VC/OAVM. All directors of the company participated in the meeting. The Company Secretary briefed members on the conduct of the AGM and the remote e-voting facility that had been provided for all business items mentioned in the meeting notice dated May 11, 2026.
The Chairman of the meeting, Mr. Arun Duggal, confirmed that quorum was present and commenced proceedings. The statutory auditors' report and secretarial audit report were noted as containing no qualifications, observations, comments, or other remarks having any adverse effect on the company's functioning.
Four ordinary resolutions as set out in the May 11, 2026 notice were placed for member approval. Members were invited to offer comments and seek clarifications, with several questions asked about the businesses before the meeting as well as company accounts and operations. Mr. Kaushal Singh Solanki, Chief Financial Officer, replied to all member questions.
The e-voting facility through CDSL platform remained open for 15 minutes after the meeting concluded at 3:55 PM. The results of the voting will be separately informed to the exchanges.
The disclosure is made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.